82
Views
0
CrossRef citations to date
0
Altmetric
Original Scientific Papers

Serum uric acid and risk of prehypertension: a dose–response meta-analysis of 17 observational studies of approximately 79 thousand participants

, , , , , , , , & ORCID Icon show all
Pages 136-145 | Received 21 Sep 2020, Accepted 13 Jan 2021, Published online: 08 Mar 2021

References

  • Cheng YB, Li Y. Hyperuricemia: does it matter for the progression from prehypertension to hypertension? Hypertension. 2018;71(1):66–67.
  • Song P, Zhang Y, Yu J, et al. Global prevalence of hypertension in children: a systematic review and meta-analysis. JAMA Pediatr. 2019;173(12):1154–1110.
  • Guo X, Zou L, Zhang X, et al. Prehypertension: a meta-analysis of the epidemiology, risk factors, and predictors of progression. Tex Heart Inst J. 2011;38(6):643–652.
  • Han M, Li Q, Liu L, et al. Prehypertension and risk of cardiovascular diseases: a meta-analysis of 47 cohort studies. J Hypertens. 2019;37(12):2325–2332.
  • Duprez D, Toleuova A. Prehypertension and the cardiometabolic syndrome: pathological and clinical consequences. Expert Rev Cardiovasc Ther. 2013;11(12):1725–1733.
  • Huang Y, Su L, Cai X, et al. Association of all-cause and cardiovascular mortality with prehypertension: a meta-analysis. Am Heart J. 2014;167(2):160–168.
  • Redwine KM, Daniels SR. Prehypertension in adolescents: risk and progression. J Clin Hypertens (Greenwich). 2012;14(6):360–364.
  • Kavey RW, Daniels SR, Flynn JT. Management of high blood pressure in children and adolescents. Cardiol Clin. 2010;28(4):597–607.
  • Darmawan G, Hamijoyo L, Hasan I. Association between Serum uric acid and non-alcoholic fatty liver disease: a meta-analysis. Acta Medica Indonesiana. 2017;49(2):136.
  • Grayson PC, Kim SY, LaValley M, et al. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res. 2011;63(1):102–110.
  • Kim SY, Guevara JP, Kim KM, et al. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2010;62(2):170–180.
  • Mazidi M, Katsiki N, Mikhailidis DP, Lipid and Blood Pressure Meta-Analysis Collaboration (LBPMC) Group, et al. Associations of serum uric acid with total and cause-specific mortality: Findings from individuals and pooling prospective studies. Atherosclerosis. 2020;296:49–58.
  • Lei L, Wang J. Dietary sodium intake and serum uric acid: a mini-review. Pulse (Basel). 2018;6(1-2):124–129.
  • Izzo R, Mancusi C, de Simone G. Are we underestimating prehypertension? Hypertension. 2019;73(3):541–542.
  • Wang J, Qin T, Chen J, et al. Hyperuricemia and risk of incident hypertension: a systematic review and meta-analysis of observational studies. PLoS One. 2014;9(12):e114259.
  • Ling L, Yanqiu W, Yaojun S, et al. Relationship between uric acid level and essential hypertension in Chinese population: a meta-analysis. J Youjiang Med Univ Nationalities. 2018;40(03):257–262.
  • Li X, Meng X, Timofeeva M, et al. Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies. BMJ. 2017;357:j2376.
  • Jiang M, Gong D, Fan Y. Serum uric acid levels and risk of prehypertension: a meta-analysis. Clin Chem Lab Med (CCLM). 2017;55(3):314–321.
  • Wu I, Wu J, Sun Z, et al. Higher serum uric acid level increases risk of prehypertension in subjects with normal glucose tolerance, but not pre-diabetes and diabetes. J Hum Hypertens. 2016;30(8):479–482.
  • Kawamoto R, Tabara Y, Kohara K, et al. Interaction between serum uric acid and triglycerides in relation to prehypertension in community-dwelling Japanese adults. Clin Exp Hypertens. 2014;36(1):64–69.
  • Viazzi F, Antolini L, Giussani M, et al. Serum uric acid and blood pressure in children at cardiovascular risk. Pediatrics. 2013;132(1):e93–e99.
  • Nery AB, Mesquita ET, Lugon JR, et al. Prehypertension and cardiovascular risk factors in adults enrolled in a primary care programme. Eur J Cardiovasc Prev Rehabil. 2011;18(2):233–239.
  • Sansanayudh N, Luvira V, Woracharoensri N, et al. Prevalence of prehypertensive state and other cardiovascular risk factors in the First Infantry Regiment, the King's own bodyguard. J Med Assoc Thailand = Chotmaihet Thangphaet. 2009;92(Suppl 1):S28.
  • Dyer A, Liu K, Walsh M, et al. Ten-year incidence of elevated blood pressure and its predictors: The CARDIA Study. Coronary Artery Risk Development in (Young) Adults. J Hum Hypertens. 1999;13(1):13–21.
  • Nakanishi N, Nakamura K, Ichikawa S, et al. Risk factors for the development of hypertension: a 6-year longitudinal study of middle-aged Japanese men. J Hypertens. 1998;16(6):753–759.
  • Wang Y, Hu JW, Qu PF, et al. Association between urinary sodium excretion and uric acid, and its interaction on the risk of prehypertension among Chinese young adults. Sci Rep. 2018;8(1):7749.
  • Jiang L, Mo D, Yang R, et al. Joint effects of serum uric acid and body mass index on risk of prehypertension in Chinese population. Clin Chim Acta. 2015;446:1–5.
  • Bao X, Wang Q, Chen G, et al. Serum concentration of uric acid associated with prehypertension among Chinese population. Angiology. 2014;65(9):800–805.
  • Kawamoto R, Ninomiya D, Senzaki K, et al. Interaction between body mass index and serum uric acid in relation to blood pressure in community-dwelling Japanese men. Clin Hypertens. 2018;24(1):1.
  • Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605.
  • Rostom A, Dubé C, Cranney A, et al. Celiac disease. 2004; [cited 2020 Sep 21]. Available from: https://www.ncbi.nlm.nih.gov/books
  • Zhang J, Yu KF. What's the Relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280(19):1690–1691.
  • Orsini N, Li R, Wolk A, et al. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol. 2012;175(1):66–73.
  • Bekkering GE, Harris RJ, Thomas S, et al. How much of the data published in observational studies of the association between diet and prostate or bladder cancer is usable for meta-analysis? Am J Epidemiol. 2008;167(9):1017–1026.
  • Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560.
  • Egger M, Davey SG, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634.
  • Hirschler V, Gonzalez C, Maccallini G, et al. Association between blood pressure and magnesium and uric acid levels in indigenous Argentinean children at high altitude. Am J Hum Biol. 2017;29(4):e22989.
  • Liu L, Gu Y, Li C, et al. Serum uric acid is an independent predictor for developing prehypertension: a population-based prospective cohort study. J Hum Hypertens. 2017;31(2):116–120.
  • Lotufo PA, Baena CP, Santos IS, et al. Serum uric acid and prehypertension among adults free of cardiovascular diseases and diabetes: baseline of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Angiology. 2016;67(2):180–186.
  • Peng H, Ding J, Peng Y, et al. Hyperuricemia and microalbuminuria are separately and independently associated with prehypertension among Chinese Han women. Metab Syndr Relat D. 2012;10(3):202–208.
  • Liang J, Xue Y, Zou C, et al. Serum uric acid and prehypertension among Chinese adults. J Hypertens. 2009;27(9):1761–1765.
  • Syamala S, Li J, Shankar A. Association between serum uric acid and prehypertension among US adults. J Hypertens. 2007;25(8):1583–1589.
  • Liu L, Zhang X, Qie R, et al. Dose–response association between serum uric acid levels and incident hypertension: a systematic review and meta-analysis of 17 prospective cohort studies of 32 thousand participants. Acta Cardiol. 2020:1–6. doi:https://doi.org/10.1080/00015385.2020.1779476
  • Whelton PK, Carey RM, Aronow WS, et al. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2017;71(6):e13–e115.
  • Whitworth JA. World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21(11):1983–1992.
  • James PA, Oparil S, Carter BL, et al. 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–520.
  • Chobanian AV, Bakris GL, Black HR. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. The JNC 7 report. ACC Curr J Rev. 2003;12(4):31–32.
  • Perlstein TS, Gumieniak O, Hopkins PN, et al. Uric acid and the state of the intrarenal renin-angiotensin system in humans. Kidney Int. 2004;66(4):1465–1470.
  • Kang DH, Park SK, Lee IK, et al. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol. 2005;16(12):3553–3562.
  • Corry DB, Eslami P, Yamamoto K, et al. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens. 2008;26(2):269–275.
  • Khosla UM, Zharikov S, Finch JL, et al. Hyperuricemia induces endothelial dysfunction. Kidney Int. 2005;67(5):1739–1742.
  • Hayden MR, Tyagi SC. Uric acid: a new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: the urate redox shuttle. Nutr Metab (Lond). 2004;1(1):10.
  • Mu H, Ohashi R, Yan S, et al. Adipokine resistin promotes in vitro angiogenesis of human endothelial cells. Cardiovasc Res. 2006;70(1):146–157.
  • Kawamoto R, Kohara K, Tabara Y, et al. Insulin resistance and prevalence of prehypertension and hypertension among community-dwelling persons. JAT. 2010;17(2):148–155.
  • Yoo TW, Sung KC, Shin HS, et al. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J. 2005;69(8):928–933.
  • Wei-Yen H, Yu-Wen C, Ying-Lan T, et al. Resistin induces monocyteendothelial cell adhesion by increasing ICAM-1 and VCAM-1 expression in endothelial cells via p38MAPK-dependent pathway. J Cell Physiol. 2011;226(8):2181–2188.
  • Antuna-Puente B, Feve B, Fellahi S, et al. Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab. 2008;34(1):2–11.
  • Soletsky B, Feig DI. Uric acid reduction rectifies prehypertension in obese adolescents. Hypertension. 2012;60(5):1148–1156.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.